Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Patients receiving opioid maintenance treatment in primary care: successful chronic hepatitis C care in a real world setting.

BMC infectious diseases - 8 Jan 2013

Seidenberg André, Rosemann Thomas, Senn Oliver

Abstract excerpt

BACKGROUND: Injection drug users (IDUs) represent a significant proportion of patients with chronic hepatitis C (CHC). The low treatment uptake among these patients results in a low treatment effectiveness and a limited public health impact. We hypothesised that a general practitioner (GP) providing an opioid maintenance treatment (OMT) for addicted patients can achieve CHC treatment and sustained virological...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Analgesics, Opioid
Share to Antiviral Agents
Share to Genotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepacivirus

Share to Hepatitis C, Chronic

Share to Substance-Related Disorders

Share to Treatment Outcome

Share to Viral Load

Source

Open in PubMed Open full text

Identifiers

PMID: 23298178
DOI: 10.1186/1471-2334-13-9
PMCID: PMC3548742

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Patients receiving opioid maintenance treatment in primary care: successful chronic hepatitis C care in a real world setting.PMID 23298178Read ↗

Management of hepatitis C virus (HCV) infection in drug substitution programs.Semantic proximity Read ↗

Successful treatment of chronic hepatitis C virus infection in severely opioid-dependent patients under heroin maintenance.Semantic proximity Read ↗

On the path towards universal coverage of hepatitis C treatment among people receiving opioid agonist therapy (OAT) in Norway: a prospective cohort study from 2013 to 2017Semantic proximity Read ↗

Epidemiology of hepatitis C virus infection among people receiving opioid substitution therapy (ECHO): study protocol.Semantic proximity Read ↗

Efficacy of peginterferon plus ribavirin in patients receiving opioid substitution therapy : Final results of the Austrian PegHope study.Semantic proximity Read ↗

Integrated internist - addiction medicine - hepatology model for hepatitis C management for individuals on methadone maintenance.Semantic proximity Read ↗

Delivery of treatment for hepatitis C virus infection in the primary care setting.Semantic proximity Read ↗

Efficacy of response-guided directly observed pegylated interferon and self-administered ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: The ACTIVATE study.Semantic proximity Read ↗

Access to care of patients with chronic hepatitis C virus infection in a university hospital: Is opioid dependence a limiting condition?Semantic proximity Read ↗

Integrated Care for the Use of Direct-acting Antivirals in Patients With Chronic Hepatitis C and Substance Use Disorder.Semantic proximity Read ↗

Impact of recent drug use on the efficacy of elbasvir/grazoprevir for HCV-infected people on opioid agonist therapy.Semantic proximity Read ↗

Substitution treatment or active intravenous drug use should not be contraindications for antiviral treatment in drug users with chronic hepatitis C.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.